Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Radtke

Showing results (51-60 of 65) with videos related to

Pageof 7
Sort By:
European Radiology|September 13, 2024
MRI characteristics predict risk of pathological upgrade in patients with ISUP grade group 1 prostate cancerM Boschheidgen, L Schimmöller, J P Radtke, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 17, 2021
Radiation Protection and Occupational Exposure on <sup>68</sup>Ga-PSMA-11-Based Cerenkov Luminescence Imaging Procedures in Robot-Assisted ProstatectomyPedro Fragoso Costa, Wolfgang P Fendler, Ken Herrmann, et al.
BJU International|November 24, 2019
External validation of novel magnetic resonance imaging-based models for prostate cancer predictionLukas Püllen, Jan P Radtke, Manuel Wiesenfarth, et al.
Molecular Imaging and Biology|September 5, 2019
Whole-Body Integrated [<sup>68</sup>Ga]PSMA-11-PET/MR Imaging in Patients with Recurrent Prostate Cancer: Comparison with Whole-Body PET/CT as the Standard of ReferenceNika Guberina, P Hetkamp, H Ruebben, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 18, 2017
Simultaneous whole-body <sup>18</sup>F-PSMA-1007-PET/MRI with integrated high-resolution multiparametric imaging of the prostatic fossa for comprehensive oncological staging of patients with prostate cancer: a pilot studyMartin T Freitag, Claudia Kesch, Jens Cardinale, et al.
Molecular Imaging and Biology|November 12, 2022
PSMA-1007 Uptake in Ganglia of the Sympathetic Trunk and Its Intra-individual ReproducibilityE Mamlins, D Schmitt, M Beu, et al.
The Journal of Urology|August 1, 2014
Comparative analysis of transperineal template saturation prostate biopsy versus magnetic resonance imaging targeted biopsy with magnetic resonance imaging-ultrasound fusion guidanceJan P Radtke, Timur H Kuru, Silvan Boxler, et al.
Prostate Cancer and Prostatic Diseases|May 18, 2016
Further reduction of disqualification rates by additional MRI-targeted biopsy with transperineal saturation biopsy compared with standard 12-core systematic biopsies for the selection of prostate cancer patients for active surveillanceJ P Radtke, T H Kuru, D Bonekamp, et al.
Prostate Cancer and Prostatic Diseases|June 17, 2015
Improved detection of anterior fibromuscular stroma and transition zone prostate cancer using biparametric and multiparametric MRI with MRI-targeted biopsy and MRI-US fusion guidanceJ P Radtke, S Boxler, T H Kuru, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 19, 2016
Local recurrence of prostate cancer after radical prostatectomy is at risk to be missed in <sup>68</sup>Ga-PSMA-11-PET of PET/CT and PET/MRI: comparison with mpMRI integrated in simultaneous PET/MRIMartin T Freitag, Jan P Radtke, Ali Afshar-Oromieh, et al.
Pageof 7

Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
European Radiology|September 13, 2024
MRI characteristics predict risk of pathological upgrade in patients with ISUP grade group 1 prostate cancerM Boschheidgen, L Schimmöller, J P Radtke, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 17, 2021
Radiation Protection and Occupational Exposure on <sup>68</sup>Ga-PSMA-11-Based Cerenkov Luminescence Imaging Procedures in Robot-Assisted ProstatectomyPedro Fragoso Costa, Wolfgang P Fendler, Ken Herrmann, et al.
BJU International|November 24, 2019
External validation of novel magnetic resonance imaging-based models for prostate cancer predictionLukas Püllen, Jan P Radtke, Manuel Wiesenfarth, et al.
Molecular Imaging and Biology|September 5, 2019
Whole-Body Integrated [<sup>68</sup>Ga]PSMA-11-PET/MR Imaging in Patients with Recurrent Prostate Cancer: Comparison with Whole-Body PET/CT as the Standard of ReferenceNika Guberina, P Hetkamp, H Ruebben, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 18, 2017
Simultaneous whole-body <sup>18</sup>F-PSMA-1007-PET/MRI with integrated high-resolution multiparametric imaging of the prostatic fossa for comprehensive oncological staging of patients with prostate cancer: a pilot studyMartin T Freitag, Claudia Kesch, Jens Cardinale, et al.
Molecular Imaging and Biology|November 12, 2022
PSMA-1007 Uptake in Ganglia of the Sympathetic Trunk and Its Intra-individual ReproducibilityE Mamlins, D Schmitt, M Beu, et al.
The Journal of Urology|August 1, 2014
Comparative analysis of transperineal template saturation prostate biopsy versus magnetic resonance imaging targeted biopsy with magnetic resonance imaging-ultrasound fusion guidanceJan P Radtke, Timur H Kuru, Silvan Boxler, et al.
Prostate Cancer and Prostatic Diseases|May 18, 2016
Further reduction of disqualification rates by additional MRI-targeted biopsy with transperineal saturation biopsy compared with standard 12-core systematic biopsies for the selection of prostate cancer patients for active surveillanceJ P Radtke, T H Kuru, D Bonekamp, et al.
Prostate Cancer and Prostatic Diseases|June 17, 2015
Improved detection of anterior fibromuscular stroma and transition zone prostate cancer using biparametric and multiparametric MRI with MRI-targeted biopsy and MRI-US fusion guidanceJ P Radtke, S Boxler, T H Kuru, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 19, 2016
Local recurrence of prostate cancer after radical prostatectomy is at risk to be missed in <sup>68</sup>Ga-PSMA-11-PET of PET/CT and PET/MRI: comparison with mpMRI integrated in simultaneous PET/MRIMartin T Freitag, Jan P Radtke, Ali Afshar-Oromieh, et al.
Pageof 7